A detailed history of Center Book Partners LP transactions in Legend Biotech Corp stock. As of the latest transaction made, Center Book Partners LP holds 75,665 shares of LEGN stock, worth $3.22 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
75,665
Previous 154,074 50.89%
Holding current value
$3.22 Million
Previous $6.82 Million 45.96%
% of portfolio
0.24%
Previous 0.45%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$43.55 - $59.88 $3.41 Million - $4.7 Million
-78,409 Reduced 50.89%
75,665 $3.69 Million
Q2 2024

Aug 12, 2024

BUY
$39.5 - $57.22 $6.09 Million - $8.82 Million
154,074 New
154,074 $6.82 Million

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $7.13B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Center Book Partners LP Portfolio

Follow Center Book Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center Book Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Center Book Partners LP with notifications on news.